Status:
COMPLETED
Incentive-based Smoking Cessation for Methadone Patients
Lead Sponsor:
University of Vermont Medical Center
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Cigarette Smoking Among Patients Currently Receiving Methadone or Buprenorphine Treatment for Opioid Dependence
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The prevalence of cigarette smoking among patients receiving opioid agonist treatment, such as methadone or buprenorphine maintenance, is more than three-fold that of the general population and is ass...
Detailed Description
The prevalence of cigarette smoking among patients receiving opioid agonist treatment, such as methadone or buprenorphine maintenance, is more than three-fold that of the general population and is ass...
Eligibility Criteria
Inclusion
- For inclusion in the proposed study, subjects must report smoking 10 or more cigarettes per day and have smoked at least that amount for the past year. Subjects must be maintained on a stable methadone or buprenorphine dose for the month before study intake, with no evidence of regular illicit-drug abuse (\<30% positive specimens for illicit drugs in the past 30 days).
Exclusion
- Participants will be excluded if they are currently pregnant and/or nursing or if they report regular THC use and are unwilling to stop before beginning the study (THC use will confound CO values when we aim to monitor smoking status).
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2013
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT00718835
Start Date
June 1 2007
End Date
June 1 2013
Last Update
February 21 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Substance Abuse Treatment Center, University of Vermont
Burlington, Vermont, United States, 05401